Concepedia

Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in China: A multicentre, non-inferiority, open-label, randomised, controlled, phase 4 trial

Haiping Chen, Shaoying Chang, Mei Mei Hu, Qing‐Bin Lu, Yuntao Zhang, Hui Wang, Yanhui Xiao, Hui Wang, Yonghong Ge, Yong Zou,

Vaccine · 2022 · 26 citations · 31 references

DOIFull text

Open access

Concepts

References

31

Vaccine hesitancy: Definition, scope and determinants

Noni E. MacDonald · Vaccine · 2015 · 5.6K citations · Full text

, , +14

Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy

Graziano Onder, Giovanni Rezza, Silvio Brusaferro · JAMA · 2020 · 4.5K citations

, , +16

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

Jamie Lopez Bernal, Nick Andrews, Charlotte Gower et al. · New England Journal of Medicine · 2021 · 3.1K citations · Full text

, , +17

The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020

China CDC Weekly · China CDC Weekly · 2020 · 3.1K citations · Full text

, , +17

Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant

New England Journal of Medicine · 2022 · 2.2K citations · Full text

, , +16